SB-219383

N/A

Report date: 2025/03/19 17:15:40
NME

Base Information

Drug NameSB-219383
Drug Alias NameSB-219383
ClassificationSmall molecules
Mechanisms of ActionAminoacyl-tRNA synthetase inhibitors
TargetsAminoacyl-tRNA synthetase
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A